KY HB 153: AN ACT relating to administrative regulations for medications for substance use disorder and declaring an emergency.

Kentucky House Bill 153 creates a new section of KRS Chapter 13A declaring administrative regulations 201 KAR 9:270 and 201 KAR 20:065 deficient and void. The bill is designated as an emergency measure, meaning it would take effect immediately upon enactment rather than after the standard effective date.

The bill creates new sections within KRS Chapters 311, 313, 314, and 315, which govern the State Board of Medical Licensure, the Board of Dentistry, the Kentucky Board of Nursing, and the Kentucky Board of Pharmacy, respectively. Each of these licensing boards is prohibited under the bill from promulgating administrative regulations that restrict or limit the prescribing, dispensing, or administering of specific medications.

The medications covered include buprenorphine-mono-product, buprenorphine-combined-with-naloxone, and any other Schedule III, IV, or V medication approved by the U.S. Food and Drug Administration for the treatment of a substance use disorder. The bill's scope therefore encompasses the full class of FDA-approved medications used in medication-assisted treatment (MAT) for substance use disorder that fall within those controlled substance schedules.

As of the latest recorded action, the bill has been referred to the House Health Services Committee.